Title:
ISOINDOLINE COMPOUNDS FOR USE IN TREATMENT OF CANCER
Document Type and Number:
Japanese Patent JP2015227343
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide novel isoindoline compounds, and pharmaceutical compositions comprising the compounds.SOLUTION: The present invention provides compounds represented by formula (V), pharmaceutical compositions comprising the compounds, and the use of the compounds in production of the pharmaceutical compositions for treating, preventing or managing various diseases or disorders. (X is C(=O) or CH; m is an integer from 0 to 3; and Rand Rare each independently H, halogen, Calkyl, or Caryloxy.)
Inventors:
GEORGE W MULLER
ALEXANDER L RUCHELMAN
ALEXANDER L RUCHELMAN
Application Number:
JP2015130254A
Publication Date:
December 17, 2015
Filing Date:
June 29, 2015
Export Citation:
Assignee:
CELGENE CORP
International Classes:
C07D401/14; A61K31/454; A61K45/00; A61P7/00; A61P9/10; A61P11/00; A61P17/00; A61P25/00; A61P25/04; A61P25/20; A61P27/02; A61P33/00; A61P35/00; A61P35/02; A61P37/06; A61P43/00
Foreign References:
| WO2007027527A2 | 2007-03-08 | |||
| WO2008027542A2 | 2008-03-06 | |||
| WO2007027527A2 | 2007-03-08 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Mami Hino
Yasuhito Suzuki
Norio Omori
Mami Hino
Yasuhito Suzuki
Previous Patent: ANTIBODY MOLECULES WHICH BIND TO IL-17A AND IL-17F
Next Patent: LIPID AND LIPID AGGREGATE CONTAINING TRANSFECTION ENHANCER ELEMENT
Next Patent: LIPID AND LIPID AGGREGATE CONTAINING TRANSFECTION ENHANCER ELEMENT